Rice A, Troendle E, Bridgett S, Firoozi Nejad B, McKinley J, Bradley D
Genome Med. 2024; 16(1):150.
PMID: 39702217
PMC: 11658175.
DOI: 10.1186/s13073-024-01409-1.
Narechania A, Bobo D, Deitz K, DeSalle R, Planet P, Mathema B
Genome Res. 2024; 34(10):1651-1660.
PMID: 39322283
PMC: 11529847.
DOI: 10.1101/gr.278594.123.
Nooruzzaman M, Johnson K, Rani R, Finkelsztein E, Caserta L, Kodiyanplakkal R
Nat Commun. 2024; 15(1):7999.
PMID: 39294134
PMC: 11411086.
DOI: 10.1038/s41467-024-51924-3.
Liu X, DeVries A
PLoS One. 2024; 19(8):e0307092.
PMID: 39178243
PMC: 11343419.
DOI: 10.1371/journal.pone.0307092.
Nooruzzaman M, Johnson K, Rani R, Finkelsztein E, Caserta L, Kodiyanplakkal R
medRxiv. 2024; .
PMID: 38946967
PMC: 11213110.
DOI: 10.1101/2024.06.14.24308523.
CMAPLE: Efficient Phylogenetic Inference in the Pandemic Era.
Ly-Trong N, Bielow C, De Maio N, Minh B
Mol Biol Evol. 2024; 41(7).
PMID: 38934791
PMC: 11232695.
DOI: 10.1093/molbev/msae134.
The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021.
Vasylyeva T, Havens J, Wang J, Luoma E, W Hassler G, Amin H
PLoS Pathog. 2024; 20(6):e1012288.
PMID: 38900824
PMC: 11218943.
DOI: 10.1371/journal.ppat.1012288.
Integrating Phylogenetic Biomarker Data and Qualitative Approaches: An example of HIV Transmission Clusters as a Sampling Frame for Semistructured Interviews and Implications for the COVID-19 Era.
Hughes S, Woods W, OKeefe K, Delgado V, Pipkin S, Scheer S
J Mix Methods Res. 2024; 15(3):327-347.
PMID: 38883973
PMC: 11178346.
DOI: 10.1177/15586898211012786.
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials.
Hedskog C, Spinner C, Protzer U, Hoffmann D, Ko C, Gottlieb R
Viruses. 2024; 16(4).
PMID: 38675889
PMC: 11053423.
DOI: 10.3390/v16040546.
Viral genome sequencing to decipher in-hospital SARS-CoV-2 transmission events.
Esser E, Schulte E, Graf A, Karollus A, Smith N, Michler T
Sci Rep. 2024; 14(1):5768.
PMID: 38459123
PMC: 10923895.
DOI: 10.1038/s41598-024-56162-7.
SARS-COV-2 SEROSURVEY OF HEALTHY, PRIVATELY OWNED CATS PRESENTING TO A NEW YORK CITY ANIMAL HOSPITAL IN THE EARLY PHASE OF THE COVID-19 PANDEMIC (2020-2021).
Choi A, Stout A, Rollins A, Wang K, Guo Q, Jaimes J
bioRxiv. 2024; .
PMID: 38405835
PMC: 10888843.
DOI: 10.1101/2024.02.13.580068.
Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses.
Rosas-Murrieta N, Rodriguez-Enriquez A, Herrera-Camacho I, Millan-Perez-Pena L, Santos-Lopez G, Rivera-Benitez J
Viruses. 2024; 16(2).
PMID: 38400014
PMC: 10892376.
DOI: 10.3390/v16020238.
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.
Srivastava K, Carreno J, Gleason C, Monahan B, Singh G, Abbad A
Immunity. 2024; 57(3):587-599.e4.
PMID: 38395697
PMC: 11066813.
DOI: 10.1016/j.immuni.2024.01.017.
Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes.
Ling-Hu T, Simons L, Dean T, Rios-Guzman E, Caputo M, Alisoltani A
Cell Rep Med. 2024; 5(1):101361.
PMID: 38232695
PMC: 10829796.
DOI: 10.1016/j.xcrm.2023.101361.
Observational studies generate misleading results about the health effects of air pollution: Evidence from chronic air pollution and COVID-19 outcomes.
Conte M, Gordon M, Swartwood N, Wilwerding R, Yu C
PLoS One. 2024; 19(1):e0296154.
PMID: 38165918
PMC: 10760733.
DOI: 10.1371/journal.pone.0296154.
The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.
Escalera A, Laporte M, Turner S, Karakus U, Gonzalez-Reiche A, van de Guchte A
Emerg Microbes Infect. 2023; 13(1):2297553.
PMID: 38112266
PMC: 10866063.
DOI: 10.1080/22221751.2023.2297553.
COVID-19 and British Columbia's volunteer search and rescue workers: risk recognition and risk mitigation.
Birnbaum D, Lam V, Havaei F, Anderson G
Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e195.
PMID: 38028901
PMC: 10654942.
DOI: 10.1017/ash.2023.463.
SARS-CoV-2 genomics and impact on clinical care for COVID-19.
Lorenzo-Redondo R, de SantAnna Carvalho A, Hultquist J, Ozer E
J Antimicrob Chemother. 2023; 78(Suppl 2):ii25-ii36.
PMID: 37995357
PMC: 10667012.
DOI: 10.1093/jac/dkad309.
SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses.
Yousif M, Rachida S, Taukobong S, Ndlovu N, Iwu-Jaja C, Howard W
Nat Commun. 2023; 14(1):6325.
PMID: 37816740
PMC: 10564906.
DOI: 10.1038/s41467-023-41369-5.
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Kehrer T, Cupic A, Ye C, Yildiz S, Bouhaddou M, Crossland N
Cell Host Microbe. 2023; 31(10):1668-1684.e12.
PMID: 37738983
PMC: 10750313.
DOI: 10.1016/j.chom.2023.08.003.